A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells
about
Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP PWD40 repeat proteins striatin and S/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2AA mammalian homolog of yeast MOB1 is both a member and a putative substrate of striatin family-protein phosphatase 2A complexesA novel calmodulin-binding protein, belonging to the WD-repeat family, is localized in dendrites of a subset of CNS neuronsA novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinomaReport of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015cDNA cloning of a novel autoantigen targeted by a minor subset of anti-centromere antibodiesDynamin, endocytosis and intracellular signalling (review).Striatins contain a noncanonical coiled coil that binds protein phosphatase 2A A subunit to form a 2:2 heterotetrameric core of striatin-interacting phosphatase and kinase (STRIPAK) complex.De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.Retroviral sequences in rheumatoid arthritis synovium.Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.Reovirus-induced alterations in gene expression related to cell cycle regulation.Striatins as plaque molecules of zonulae adhaerentes in simple epithelia, of tessellate junctions in stratified epithelia, of cardiac composite junctions and of various size classes of lateral adherens junctions in cultures of epithelia- and carcinoGIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signalingMolecular modeling and molecular dynamics simulations based structural analysis of the SG2NA protein variants.Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.Tumor-associated antigen arrays for the serological diagnosis of cancer.STRIPAK complexes: structure, biological function, and involvement in human diseases.Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).SOcK, MiSTs, MASK and STicKs: the GCKIII (germinal centre kinase III) kinases and their heterologous protein-protein interactions.STRIPAK complexes in cell signaling and cancer.Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015.Silencing of STRN4 suppresses the malignant characteristics of cancer cells.Antinuclear antibodies as potential markers of lung cancer.GSK3β and ERK regulate the expression of 78 kDa SG2NA and ectopic modulation of its level affects phases of cell cycle.Anti-ribosomal-P antibodies in a Sjögren syndrome patient associated with lupus erythematosus.Dr Eng M. Tan: a tribute to an enduring legacy in autoimmunity.SG2NA is a regulator of endoplasmic reticulum (ER) homeostasis as its depletion leads to ER stress.Combinatorial expression patterns of individual TLE proteins during cell determination and differentiation suggest non-redundant functions for mammalian homologs of Drosophila Groucho.
P2860
Q24318358-499D98BE-C4E4-4333-B157-F988E47BE1F4Q24608094-8B051090-047D-4BD6-B6E5-5E42F0382405Q24608914-20B0AFE5-8E03-448A-B5AA-8535D4C1E16AQ24671652-413D5A18-8443-4C9D-B3D4-6699AA715B4CQ24676730-2F2C782B-BEE7-4DF2-B8E0-2189EBCE0C4EQ26782805-C1619605-F1AF-4E8B-8F52-2250E9DAD71CQ28115662-9060F6C9-087D-4D28-8241-E0D4D96CA18CQ30176794-0F975A16-80AF-4F82-B315-81C12B12669EQ30359226-E40A9BFF-BF38-45EA-9B11-61BB577CF19DQ31938591-E02BBDCF-6E63-4B1A-8776-25B07C8BAF72Q33493776-77B04627-19C8-40E0-94AB-FBCCCA2EF10EQ33536187-5DCA7DBC-A39F-41A7-A3B7-4640014C5D35Q34219323-7EF505CF-33D7-4A83-99DC-0E3AA727CD7EQ34332403-9FA5F1B2-6AAD-4F65-8E38-2B36997BB70FQ35123198-9916D33E-B26E-411D-8E3E-AB4DBECA6AE7Q35131603-B2B407B5-53B6-4E90-9B60-9243B20E21C7Q35205679-F9179906-5B5A-4EF9-9E35-CDB6D7FBED9FQ36169087-63890C6D-6EFB-406D-80E4-E6F200E697ACQ36491988-1DC75DF2-9099-4A6D-B30C-EB25669F01B2Q37590616-18360874-B82E-4A24-8982-E6AEF6C149C0Q37724875-AF1ECB09-52F7-4D83-88C7-AEC8D0CB96A0Q38107971-55AE35F0-3E49-420B-8691-E4BA5C016902Q38124367-E0FE14F5-D211-448D-A48A-C8B930E03266Q38733181-A7A7B64E-E53A-4ACF-B9F1-3CA59208C885Q38851088-1D97AD2E-B53E-49D3-BBAC-183200573D62Q38953772-C46D04F9-D8F7-4052-B18C-CAAC0F1EA5A4Q40944858-3DADA599-0A2B-4523-BF58-1F63E5D0C27BQ41308416-70798FCD-ABA5-4F2C-A844-51631E5CA1A7Q45239703-69A12BAE-CF36-422B-A79F-676A435FB81CQ47187009-BD19DC8F-7209-40CF-8C2B-A1846C4D33E0Q50932671-3A89D4F6-F64E-4C19-9ACD-35284AD5C8A7Q52188309-6FCF5F69-C83E-4111-AB01-07642B7A255F
P2860
A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@ast
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@en
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@nl
type
label
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@ast
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@en
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@nl
prefLabel
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@ast
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@en
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@nl
P356
P1476
A cell-cycle nuclear autoantig ...... mainly in S and G2 phase cells
@en
P2093
P304
P356
10.1006/BBRC.1995.1288
P407
P577
1995-02-01T00:00:00Z